Literature DB >> 7213501

Salivary elimination of pyrimethamine.

R A Ahmad, H J Rogers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7213501      PMCID： PMC1401699          DOI： 10.1111/j.1365-2125.1981.tb01114.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  8 in total

1.  Persistent excretion of pyrimethamine following oral administration.

Authors:  C C SMITH; J IHRIG
Journal:  Am J Trop Med Hyg       Date:  1959-01       Impact factor: 2.345

Review 2.  Therapeutic drug monitoring in saliva.

Authors:  M Danhof; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

3.  Relationship between the pharmacokinetics and pharmacodynamics of procainamide.

Authors:  R L Galeazzi; L Z Benet; L B Sheiner
Journal:  Clin Pharmacol Ther       Date:  1976-09       Impact factor: 6.875

4.  Lipid-soluble inhibitors of dihydrofolate reductase. I. Kinetics, tissue distribution, and extent of metabolism of pyrimethamine, metoprine, and etoprine in the rat, dog, and man.

Authors:  J C Cavallito; C A Nichol; W D Brenckman; R L Deangelis; D R Stickney; W S Simmons; C W Sigel
Journal:  Drug Metab Dispos       Date:  1978 May-Jun       Impact factor: 3.922

5.  Pharmacokinetics of tolbutamide: prediction by concentration in saliva.

Authors:  S B Matin; S H Wan; J H Karam
Journal:  Clin Pharmacol Ther       Date:  1974-12       Impact factor: 6.875

6.  Treatment of meningeal leukemia with pyrimethamine.

Authors:  G F Geils; C W Scott; C M Baugh
Journal:  Blood       Date:  1971-08       Impact factor: 22.113

7.  Determination of plasma concentrations of dapsone, monoacetyl dapsone and pyrimethamine in human subjects dosed with maloprim.

Authors:  C R Jones; S M Ovenell
Journal:  J Chromatogr       Date:  1979-06-11

8.  Pharmacokinetics and protein binding interactions of dapsone and pyrimethamine.

Authors:  R A Ahmad; H J Rogers
Journal:  Br J Clin Pharmacol       Date:  1980-11       Impact factor: 4.335
  8 in total
  4 in total

Review 1.  Clinical pharmacokinetics of antimalarial drugs.

Authors:  N J White
Journal:  Clin Pharmacokinet       Date:  1985 May-Jun       Impact factor: 6.447

2.  Binding of pyrimethamine to human plasma proteins and erythrocytes.

Authors:  A C Rudy; W J Poynor
Journal:  Pharm Res       Date:  1990-10       Impact factor: 4.200

Review 3.  Systemic and Target-Site Pharmacokinetics of Antiparasitic Agents.

Authors:  Valentin Al Jalali; Markus Zeitlinger
Journal:  Clin Pharmacokinet       Date:  2020-07       Impact factor: 6.447

4.  Kinetics of pyrimethamine in young and adult rats on a standard diet and on a low-protein diet.

Authors:  J B Mouankie; W Senczuk; E Florek
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2009 Jul-Sep       Impact factor: 2.569
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.